(107 days)
Not Found
No
The summary describes image processing for noise reduction but does not mention AI, ML, or related terms, nor does it describe training or testing methodologies typical of AI/ML systems.
No
The device processes and enhances MRI images for diagnostic purposes, but it does not directly treat or cure any medical condition, which is the definition of a therapeutic device.
No
The device is described as processing and enhancing MRI images by reducing noise, and it is explicitly stated that "The device processing is not effective for lesion, mass, or abnormalities of sizes less than 1.5mm." This indicates it's an image processing tool, not a device used to identify, detect, or assist in diagnosing a condition directly. Its purpose is to improve the quality of images for human interpretation, rather than providing a diagnostic output itself.
Yes
The device is explicitly described as a "software package" that runs on a PC server and processes images received over a network. There is no mention of proprietary hardware or hardware components included with the device.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze biological samples: In Vitro Diagnostics are designed to examine specimens taken from the human body, such as blood, urine, tissue, etc., to provide information about a person's health.
- This device processes medical images: The iQMR device processes MRI images, which are generated by a medical imaging modality (MRI scanner) and represent anatomical structures, not biological samples.
- The intended use is image processing and enhancement: The description clearly states the device's purpose is "networking, communication, processing and enhancement of MRI images." This is a function related to medical imaging, not in vitro analysis.
Therefore, the iQMR falls under the category of a medical image processing device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The iQMR is intended for networking, communication, processing and enhancement of MRI images in DICOM format. The device processing is not effective for lesion, mass, or abnormalities of sizes less than 1.5mm. This device is indicated for use by qualified trained medical professionals.
Product codes
LLZ
Device Description
iQMR is a software package that is aimed to process MRI images. The iQMR processing enhances MRI images by reduction of the image noise. The software runs on a PC server, which is connected to the Local Area Network (LAN). The device receives MRI images from different work stations over the network in DICOM format, processes the images and transmits them in DICOM format, to selected work stations.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
MRI
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
qualified trained medical professionals
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Non-Clincal tests: The device software has been verified by testing the software following predefined software test plan. The iQMR system has been verified by testing that it meets its specified performance, using MRI standard phantoms. The iQMR performance has been validated by testing it performing its intended and indications for use, in end-user environment.
Clinical tests: Clinical tests were not conducted. However, MRI clinical images were processed in order to ensure that the iQMR conforms to defined user needs and intended uses under actual conditions.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Medic Vision - Imaging Solutions Ltd % Mr. Dan Laor Q&R Advisor 6 Sireni St. Haifa, 3297206 ISRAEL
Re: K173605
Trade/Device Name: iOMR Regulation Number: 21 CFR 892,2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: February 19, 2018 Received: February 27, 2018
Dear Mr. Laor:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
March 8, 2018
1
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice
(https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Robert Sauer
for Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K173605
Device Name iQMR
Indications for Use (Describe)
The iQMR is intended for networking, communication, processing and enhancement of MRI images in DICOM format. The device processing is not effective for lesion, mass, or abnormalities of sizes less than 1.5mm. This device is indicated for use by qualified trained medical professionals.
Type of Use (Select one or both, as applicable)
| ☒ Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary of Safety and Effectiveness
Submitter details
Medic Vision Imaging Solutions Ltd. 3 Yozma St, Tirat Carmel 39032, Israel
Telephone +972.73.7262226
Submission Contact: Dan Laor Israel.
Details of the submitted Device
| Proprietary Name: | iQMR |
|---|---|
| Regulation Number | 892.2050 |
| Product Code: | LLZ |
| Committee/Panel: | Radiology |
| Device Class: | 2 |
6 Sireni St., Haifa, 3297206,
Type of 510(k) Submission:
Traditional
Identification of the Legally Marketed Predicate Device K993802 SharpView
Device Description
iQMR is a software package that is aimed to process MRI images. The iQMR processing enhances MRI images by reduction of the image noise. The software runs on a PC server, which is connected to the Local Area Network (LAN). The device receives MRI images from different work stations over the network in DICOM format, processes the images and transmits them in DICOM format, to selected work stations.
Intended use and indications for Use
The iQMR is intended for networking, communication, processing and enhancement of MRI images in DICOM format. The device processing is not effective for lesion, mass, or abnormalities of sizes less than 1.5mm. This device is indicated for use by qualified trained medical professionals.
Technological Characteristics
The iQMR software package is installed in an off-the-shelf PC server, which include off-the -shelf graphical boards. The Operating System is Linux Ubuntu. The iQMR software package consists of three software modules: The User Interface, Algorithm, and Interface module. Data inputs and output are MRI images in DICOM format.
Performance Tests
Non-Clincal tests
The device software has been verified by testing the software following predefined software test plan.
The iQMR system has been verified by testing that it meets its specified performance, using MRI standard phantoms.
The iQMR performance has been validated by testing it performing its intended and indications for use, in end-user environment.
Vol_003 002_510K Summary
4
The above testing methods adhered to state-of-art standards and procedures. The tests results demonstrate that the device output meet the design input and the intended use.
Clinical tests:
Clinical tests were not conducted. However, MRI clinical images were processed in order to ensure that the iQMR conforms to defined user needs and intended uses under actual conditions.
Risk Management
The device risks were managed and controlled following the requirements of ISO 14971standard. The device hazards were identified, their risk levels were evaluated and mitigation measures were taken to reduce the risk levels. In Medic Vision opinion the benefits of providing the iQMR features, overweight the device residual risks.
Substantial Equivalence
| Parameter | Predicate Device
SharpView (K993802) | Subject Device
iQMR |
|------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------|
| Intended use | Intended for use by qualified
trained medical professionals for
enhancement of MRI images that
are transferred in the network in
DICOM format. | The same |
| 21CFR section | 892.2050 | The same |
| Product Code | LLZ | The same |
| Technological
Characteristics | | |
| Device nature | SW package | The same |
| Operating System | Windows | Linux |
| Data input | MRI images in DICOM format | The same |
| Data output | MRI images in DICOM format | The same |
| Processing
Algorithms | GOP Enhancement Software | Medic Vision's
Algorithms |
| User Interface | Included | The same |
Comparison with the predicate device
Substantial Equivalence conclusion
The iQMR has the same intended use as the legally marketed SharpView predicate device. The two devices have similar technological characteristics. Results of tests, which were adhered to state-of-art standards and procedures, demonstrate that differences in the technological characteristics do not raise new questions of safety or effectiveness. Based on this discussion, it is Medic Vision's opinion that iQMR is substantially equivalent in terms of safety and effectiveness to the SharpView (K993802) predicate device.